Cephalon

Cephalon is a global biopharmaceutical company dedicated to discovering, developing, and marketing drugs to improve the quality of life for individuals worldwide. Since its founding in 1987, Cephalon has brought first-class and best-in-class drugs to patients across multiple therapeutic areas. As one of the fastest-growing biopharmaceutical companies in the world, Cephalon has become a Fortune 1000 company and a member of the S&P 500 index, with approximately 4,000 employees globally. The company sells numerous branded and generic products worldwide. In total, Cephalon markets over 150 products across nearly 100 countries.